Publications by authors named "Giulia Ceccardi"

Claim this Profile
A
Anti-CGRP monoclonal antibodies, migraine and mood disorders: an observational study.
Marco Bolchini, Giulia Ceccardi, Francesca Schiano di Cola, Michele Di Pasquale, Renata Rao

Neurol Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study.
Eleonora Colombo, Alberto Doretti, Renata Rao, Federico Verde, Martina Sodano, Giulia Ceccardi

Neurol Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased risk of functional neurological disorders following SARS-CoV-2 vaccination.
Andrea Pilotto, Marcello Catania, Irene Mattioli, Nicola Zoppi, Giulia Ceccardi

Eur J Neurol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine.
Giulia Ceccardi, Francesca Schiano di Cola, Salvatore Caratozzolo, Michele Di Pasquale, Marco Bolchini

Toxins (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An observational study on monoclonal antibodies against calcitonin-gene-related peptide and its receptor.
Francesca Schiano di Cola, Marco Bolchini, Giulia Ceccardi, Salvatore Caratozzolo, Paolo Liberini

Eur J Neurol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab.
Marco Bolchini, Francesca Schiano di Cola, Giulia Ceccardi, Salvatore Caratozzolo, Paolo Liberini

Eur Neurol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine.
Francesca Schiano di Cola, Marco Bolchini, Salvatore Caratozzolo, Giulia Ceccardi, Matteo Cortinovis

Neurol Int· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photophobia and migraine outcome during treatment with galcanezumab.
Francesca Schiano di Cola, Giulia Ceccardi, Marco Bolchini, Salvatore Caratozzolo, Paolo Liberini

Front Neurol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post COVID-19 vaccination headache: A clinical and epidemiological evaluation.
Giulia Ceccardi, Francesca Schiano di Cola, Marco Di Cesare, Paolo Liberini, Mauro Magoni

Front Pain Res (Lausanne)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients.
Francesca Schiano di Cola, Salvatore Caratozzolo, Marco Bolchini, Giulia Ceccardi, Matteo Cortinovis

Neurol Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features and outcomes of the flail arm and flail leg and pure lower motor neuron MND variants: a multicentre Italian study.
Paride Schito, Giulia Ceccardi, Andrea Calvo, Yuri Matteo Falzone, Cristina Moglia

J Neurol Neurosurg Psychiatry· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis